Open Access Open Access  Restricted Access Subscription Access

Etiology, Epidemiology, Diagnosis, Differential Diagnosis, Treatment, Prognosis and Complications of Epstein Bar Virus

Srinivas G., Ramanjaneyulu D.V., Satyanarayana Murthy S., Muralinath E., Guruprasad M., Sravani Pragna K., Manjari P., Sony Sharlet E., T. Nikhil, V. Yaswanth Sai, Kasireddy Gautam, Moopori Kalyan, Sai Charan B., Ragada Sanjan

Abstract


One of the most prevalent human viruses worldwide is the Epstein-Barr virus, or EBV. EBV belongs to the herpes virus family and is often referred to as human herpesvirus 4. The majority of people will have EBV at some point in their lives, particularly during childhood, and will not exhibit any symptoms. Children infected with EBV typically either have no symptoms at all or symptoms that are indistinguishable from those of other minor, transient childhood illnesses. Infectious mononucleosis and asymptomatic EBV infection are also possible. Although they are uncommon, complications should be recognized. The assessment and treatment of Epstein-Barr virus are explained in this exercise, along with the function of the interprofessional team in managing patients with this illness.


Full Text:

PDF

References


Odumade, O. A., Hogquist, K. A., & Balfour Jr, H. H. (2011). Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clinical microbiology reviews, 24(1), 193-209. https://doi.org/10.1128/cmr.00044-10

Womack, J., & Jimenez, M. (2015). Common questions about infectious mononucleosis. American family physician, 91(6), 372-376. https://www.aafp.org/pubs/afp/issues/2015/0315/p372.html

Balfour Jr, H. H., Schmeling, D. O., & Grimm-Geris, J. M. (2020). The promise of a prophylactic Epstein–Barr virus vaccine. Pediatric research, 87(2), 345-352.

Yu, H., & Robertson, E. S. (2023). Epstein–Barr virus history and pathogenesis.Viruses, 15(3), 714. https://doi.org/10.3390/v15030714

Ruprecht, K. (2020). The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review. Expert review of clinical immunology, 16(12),1143-1157. https://doi.org/10.1080/1744666X.2021.1847642

Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B., & Hislop, A. D. (2015). The immunology of Epstein-Barr virus–induced disease. Annual review of immunology, 33(1), 787-821. https://doi.org/10.1146/annurev-immunol-032414-112326

Bale Jr, J. F. (2015). Virus and immune-mediated encephalitides: epidemiology, diagnosis, treatment, and prevention. Pediatric neurology, 53(1),3-12. https://doi.org/10.1016/j.pediatrneurol.2015.03.013

Bunchorntavakul, C., & Reddy, K. R. (2020). Epstein-Barr virus and cytomegalovirus infections of the liver. Gastroenterology Clinics, 49(2), 331-346. https://doi.org/10.3389/fimmu.2017.01867

Nijland, M. L., Kersten, M. J., Pals, S. T., Bemelman, F. J., & Ten Berge, I. J.(2016). Epstein-Barr virus–positive posttransplant lymphoproliferative disease after solid organ transplantation: pathogenesis, clinical manifestations, diagnosis, and management. Transplantation direct, 2(1), e48. 10.1097/TXD.0000000000000557

Jenson, H. B. (2000). Acute complications of Epstein-Barr virus infectious mononucleosis. Current opinion in pediatrics, 12(3), 263-268. https://journals.lww.com/co-pediatrics/abstract/2000/06000/acute_complications_of_epstein_barr_virus.16.aspx

Lupo, J., Truffot, A., Andreani, J., Habib, M., Epaulard, O., Morand, P., & Germi, R. (2023). Virological markers in Epstein–Barr virus-associated diseases. Viruses, 15(3), 656. https://doi.org/10.3390/v15030656

Rapp, C. E., & Hewetson, J. F. (1978). Infectious mononucleosis and the Epstein-Barr virus. American Journal of Diseases of Children, 132(1), 78-86. 10.1001/archpedi.1978.02120260080020

Okano, M. (2002). Overview and problematic standpoints of severe chronic active Epstein–Barr virus infection syndrome. Critical reviews in oncology/hematology, 44(3), 273-282. https://doi.org/10.1016/S1040-8428(02)00118-X

Ok, C. Y., Li, L., & Young, K. H. (2015). EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management. Experimental & Molecular Medicine, 47(1), e132-e132. https://www.nature.com/articles/emm201482

Dunmire, S. K., Verghese, P. S., & Balfour Jr, H. H. (2018). Primary epstein-barr virus infection. Journal of Clinical Virology, 102, 84-92. https://www.sciencedirect.com/science/article/abs/pii/S1386653218300635


Refbacks

  • There are currently no refbacks.